Abstract 73P
Background
Tumor infiltration by nerves and axial bone metastases often occur in prostate cancer (PCa) patients, however the mechanisms and the link between these processes are not well understood. Here, we report a PCa mouse model, which recapitulates this cancer route of spreading and correlates with radiological images from PCa patients.
Methods
The human androgen-independent PC3-ML cell line with reported bone metastasis potential was orthotopically injected into the prostate of SCID/Bg mice to observe the natural history of cancer spread instead of commonly used intratibial or intracardiac injections. The process of primary and secondary tumor development was monitored by magnetic resonance imaging (MRI). The tissues were collected and immunostained for neuronal markers, neurofilament (NF), and tyrosine hydroxylase (TH), as well as prostate cancer cell marker, pan-cytokeratin, and a vascular marker, CD31. Additionally, clinical cases of patients with representative MRI images of bone metastases and PNI were selected.
Results
The mice MRI revealed the presence of primary prostate tumor with secondary tumors located mostly along the lumbar spinal cord and pelvis, which led to secondary bone infiltration. The histopathological analysis confirmed the presence of PCa cells along the spine with its infiltration. The PCa cells created clusters, which spread along the small, NF-positive nerve fibers that were directed into the bone area. We ruled out the retrograde vessel infiltration by CD31 immunostaining. The clinical relevance of our model was confirmed by the radiological presentation of human PCa cases: 1) a patient with castration-sensitive PCa, with oligometastatic disease (one sacrum metastasis) and infiltration of neurovascular bundle; 2) a patient with castration-resistant PCa with PNI and a relapse in the ilium, who subsequently developed perispinal metastases along the lumbar plexus and spine.
Conclusions
Altogether, the results of our study suggest that PNI may be responsible for the initial PCa dissemination to bone. MRI imaging has adequate sensitivity to detect the nerve infiltration, however it is not commonly used in disseminated PCa patients. Consequently, the number of cases with spine infiltration and bone metastases may be underreported.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Georgetown University Medical Center.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
4P - Spatially resolved transcriptome elucidates bidirectional tertiary lymphoid structure interacts with tumor microenvironment of non-small cell lung cancer
Presenter: Xin Zhao
Session: Poster session 09
5P - Tertiary lymphoid structures (TLS) presence and stromal blood vessels heterogeneity differentially influence recurrence, lymphovascular, and perineural invasion in breast cancer molecular subtypes
Presenter: Andrei Cosma
Session: Poster session 09
6P - Combined single-cell and spatially resolved mapping of the human lymph node ecosystem reveals fundamental principles of lymphoma tissue organization
Presenter: Daniel Hübschmann
Session: Poster session 09
7P - Engineered salmonella blocks cancer metastasis by activating NK cells in an IFN-γ-dependent manner
Presenter: JIANDONG HUANG
Session: Poster session 09
8P - Modulating tumor microenvironment using a VEGF active immunotherapeutic approach in gastrointestinal tumors: Beyond angiogenesis modulation
Presenter: Mónica Bequet-Romero
Session: Poster session 09
9P - Identification of a μCT-based radiomic signature of CD8+ tumour infiltrating lymphocytes in an orthotopic murine model
Presenter: Giulia Mazzaschi
Session: Poster session 09
10P - Cancer cells induce intracellular gap formation in sinusoidal endothelial cells to produce liver metastasis through pro-inflammatory paracrine mechanisms
Presenter: Hoang Truong
Session: Poster session 09
11P - Targeting stromal cells to reverse immune suppression in triple-negative breast cancer
Presenter: Julia Chen
Session: Poster session 09
12P - Immuno-suppressive role of tumour-derived GDF-15 on myeloid cells
Presenter: Christine Schuberth-Wagner
Session: Poster session 09
13P - Disrupting the immunosuppressive tumor microenvironment using genetically engineered macrophages for triple-negative breast cancer therapy
Presenter: Sabrina Traxel
Session: Poster session 09